Product Number |
OAAB06426 |
Product Page |
www.avivasysbio.com/hla-drb5-antibody-center-region-oaab06426.html |
Name |
HLA-DRB5 Antibody - middle region (OAAB06426) |
Molecular Weight |
30056 Da |
Isotype |
Rabbit Ig |
NCBI Gene Id |
3127 |
Host |
Rabbit |
Clonality |
Polyclonal |
Concentration |
Approximately 0.5mg/ml. Actual concentration varies with each lot. |
Alias Symbols |
HLA-DRB5* |
Product Format |
Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. |
Reconstitution and Storage |
Maintain refrigerated at 2-8C for up to 2 weeks. For long term storage store at -20C in small aliquots to prevent freeze-thaw cycles. |
Datasheets/Manuals |
Printable datasheet for anti-HLA-DRB5 antibody - OAAB06426 |
Application Info |
WB: 1:1000 IHC-P: 1:50~100 |
Immunogen |
This HLA-DRB5 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 43-70 amino acids from the Central region of human HLA-DRB5. |
Uniprot ID |
Q30154 |
Protein Name |
HLA class II histocompatibility antigen, DR beta 5 chain |
Publications |
Molecular Characteristics of High-Dose Melphalan Associated Oral Mucositis in Patients with Multiple Myeloma: A Gene Expression Study on Human Mucosa. PLoS ONE. 12, e0169286 (2017). 28052121 |
Sample Type Confirmation |
HLA-DRB5 is strongly supported by BioGPS gene expression data to be expressed in HL60 |
Protein Accession # |
NP_002116.2 |
Purification |
This antibody is purified through a protein A column, followed by peptide affinity purification. |
Gene Symbol |
HLA-DRB5 |
Predicted Species Reactivity |
Human |
Application |
WB, IHC |
Predicted Homology Based on Immunogen Sequence |
Human |
Image 1 | HL-60
| Western blot analysis of HLA-DRB5 Antibody (Center) in HL-60 cell lysates (35ug/lane). HLA-DRB5 (arrow) was detected using the purified Pab. HLA-DRB5 is strongly supported by BioGPS gene expression data to be expressed in HL60 |
| Image 2 | human lung carcinoma
| HLA-DRB5 Antibody (Center) immunohistochemistry analysis in formalin fixed and paraffin embedded human lung carcinoma followed by peroxidase conjugation of the secondary antibody and DAB staining. This data demonstrates the use of the HLA-DRB5 Antibody (Center) for immunohistochemistry. Clinical relevance has not been evaluated. |
|
|